Success Stories: EB-2 NIW Granted for Psychologist through Research and Clinical Contributions in Partner Violence Intervention
Client’s Testimonial:
“I am impressed with the services North America Immigration Law Group (NAILG) has provided. Every step of the process is laid out in thorough and clear instructions, including at the early stage with instructions on what information to submit for a free evaluation. During package preparation, the attorneys made sure to promptly answer all my questions. They also paid close attention to the details of my case to maximize its chance at success. In addition, they were very collaborative and respectful of my schedule/pace. I was referred to NAILG by a friend who got their NIW case approved, and I would recommend their services to others in the future.”
On August 25th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Psychologist in the Field of Experimental Psychology (Approval Notice).
General Field: Experimental Psychology
Position at the Time of Filing: Postdoctoral Researcher at Yale University, and Psychotherapist at the Chicago Center for Relationship Counseling
Country of Origin: Vietnam
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: August 25th, 2025
Processing Time: 1 year, 7 months, 17 days
Case Summary:
Intimate partner violence (IPV) remains a significant public health concern in the United States, with profound social, economic, and healthcare impacts. This clinician-researcher has devoted her career to executing clinical trials and applying evidence-based therapeutic interventions to address IPV, focusing on assessing the effectiveness of group/individual treatments for perpetrators while simultaneously providing psychotherapeutic support to survivors. Her work directly contributes to improving recovery outcomes and mitigating the societal and economic consequences of IPV.
Innovative Research with National Impact
Her research develops and implements interventions that serve as critical tools for both preventing future IPV incidents and supporting survivor recovery. By applying evidence-based approaches, her work enhances the well-being of affected populations, promotes faster socio-economic reintegration, and reduces healthcare costs nationally. The significance of her research is underscored by funding from the Association of Behavioral and Cognitive Therapies (ABCT).
Academic and Professional Contributions
The researcher holds a Ph.D. in Experimental Psychology and has established a record of impactful scholarship:
- 11 peer-reviewed journal articles (2 first-authored), 2 technical reports
- 34 citations to her published work
- At least 5 peer reviews completed for scholarly journals
- Served as a symposium chair twice at the Association for Behavioral and Cognitive Therapies Annual Conference
Her consistent ability to conduct rigorous clinical studies and generate evidence-based results demonstrates her potential to continue advancing public health initiatives and IPV interventions in the United States.
Expert Recognition
An expert in the field noted:
“[Client] is well-positioned to continue advancing the field’s understanding of key factors that impact the health and well-being of marginalized populations in the U.S. She has demonstrated this throughout her career, especially in her formation of strong, unique research questions and her high proficiency in the analytical skills necessary for producing high-quality results. [Client] is undeniably an asset to the U.S., and she is more than deserving of the opportunity to continue her research in this country.”
NAILG’s Role and Approval
North America Immigration Law Group (NAILG) prepared a comprehensive petition emphasizing the national importance of her research, her leadership in clinical research, and her ability to produce meaningful, evidence-based interventions. By highlighting her funding, publications, peer-review activities, and professional leadership roles, NAILG presented a compelling case to USCIS. The petition was approved, affirming that her continued research and clinical work will support U.S. public health, accelerate recovery for IPV survivors, and contribute to the nation’s societal and economic well-being.